Company intelligence / Profile preview
Kyorin Pharmaceutical
Chiyoda-ku, Tokyo, Japankyorin-pharm.co.jp ↗
- Ownership
- Public · 4569
- Employees
- ~2042
- Development stage
- Commercial
01
Overview
Kyorin Pharmaceutical has over a century of experience in drug discovery and commercialization. The company markets more than160 drugs and diagnostics, with over30 active clinical programs spanning respiratory, otolaryngology, urology, infectious disease, rare/intractable diseases. Notable recent launches include Lyfnua® Tablets for refractory chronic cough and Zonisamide OD tablets for Parkinson’s disease. The company also partners globally on late-stage assets such as efzofitimod for pulmonary sarcoidosis.
- Therapeutic areas
- PulmonologyMen's HealthOtherRare DiseasesInfectious Diseases
- Modalities
- Small moleculeBiologicDiagnostic device
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
Request access →03
Partnerships
aTyr Pharma Inc. – development/commercialization of efzofitimod in Japan for ILD/pulmonary sarcoidosisASKA Pharmaceutical – joint development/sales of AKP‑009 for benign prostatic hyperplasiaMSD K.K. – exclusive distribution rights in Japan for Lyfnua® TabletsLumen Bioscience – spirulina genetic protein engineering technologyCellGenTech – Fabry disease programSUSMED Inc. – digital therapeutics collaboration
Beyond the preview
Go deeper on Kyorin Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kyorin Pharmaceutical.